Clik here to view.
How etectRx’s “smart pill” aims to improve patient compliance trends
When Harry Travis first met Neil Euliano and learned about his medication adherence technology, the pharmaceutical industry was beginning to usher in the age of pricey drugs with Hepatitis C therapies...
View ArticleClik here to view.
Baxter’s profits nearly double during Street-beating Q3
Baxter (NYSE:BAX) nearly doubled its profits during the third quarter and handily beat the consensus expectation on Wall Street. The Chicago-area healthcare giant posted profits of $251 million, or 45¢...
View ArticleClik here to view.
Baxter touts minimal albumin loss in Theranova HDx therapy studies
Baxter (NYSE:BAX) today released data from a study of expanded hemodialysis using its Theranova dialyzer, touting that the device was shown to successfully remove mid-sized uremic toxins from the body...
View ArticleClik here to view.
Here’s what the FDA is doing about IV fluid shortages following hurricanes...
Nine weeks after hurricanes Maria and Irma brought devastation to Puerto Rico, FDA commissioner Dr. Scott Gottlieb says hospitals across the U.S. are reporting shortages of IV fluids – medical products...
View ArticleClik here to view.
FDA’s Gottlieb updates on Puerto Rico and medical product shortages
FDA commissioner Dr. Scott Gottlieb provided an update today to the work that the agency is doing to help medical device manufacturers in Puerto Rico in the weeks following Hurricanes Irma and Maria....
View ArticleClik here to view.
Illinois AG sues Baxter for polluting lake
Illinois attorney general Lisa Madigan hit Baxter Healthcare (NYSE:BAX) with a lawsuit yesterday, alleging that the company’s R&D facility dumped contaminated wastewater into a tributary that feeds...
View ArticleClik here to view.
Baxter buys Mallinckrodt’s Recothrom, Preveleak sealants for $153m
Baxter (NYSE:BAX) said today it inked an agreement with Mallinckrodt Pharmaceuticals (NYSE:MNK) to acquire its Recothrom and Preveleak hemostat and sealant products for approximately $153 million up...
View ArticleClik here to view.
FDA’s Gottlieb updates on IV bag shortages after Hurricane Maria
[Image courtesy of NOAA]FDA commissioner Dr. Scott Gottlieb expects that the shortage of IV fluids caused by Hurricane Maria in Puerto Rico will improve in the coming weeks and months, according to a...
View ArticleClik here to view.
Is tax reform good or bad for medical device companies?
Medical device companies and others in the healthcare sector stand to benefit from the tax reform Congress passed at the end of 2017, but the picture isn’t entirely rosy, according to a new report from...
View ArticleClik here to view.
Baxter subsidiary sues B. Braun over blood filtration system
Baxter (NYSE:BAX) and its subsidiary Gambro filed a patent infringement lawsuit against B. Braun last week, claiming that the German medical device maker’s Omni blood purification system infringes on...
View ArticleClik here to view.
Baxter posts Street-beating Q4 earnings, sales
Shares in Baxter (NYSE:BAX) fell slightly this morning after the company topped expectations on Wall Street with its fourth quarter and full-year results. The Deerfield, Ill.-based company swung to a...
View ArticleClik here to view.
The flu season is making a shortage of IV fluids worse – here’s what the FDA...
This year’s flu season has been exceptionally bad – it’s already claimed the lives of dozens of kids and it’s more widespread than any other year on record, according to the Centers for Disease Control...
View ArticleClik here to view.
InVivo Therapeutics lifts Toselli to permanent prez, CEO | Personnel Moves...
InVivo Therapeutics (NSDQ:NVIV) said yesterday it made Dr. Richard Toselli’s spot in the corner office permanent, lifting him from acting CEO to prez and CEO. Dr. Toselli will maintain his position on...
View ArticleClik here to view.
Baxter approves $1.5B addition to share repurchase plan
Baxter (NYSE:BAX) said today its board of directors approved a $1.5 billion addition to its existing share repurchasing plan. With the approval, the company’s share repurchasing plan has approximately...
View ArticleClik here to view.
Baxter closes $153m hemostat, sealant asset buy from Mallinckrodt
Baxter (NYSE:BAX) said today that it closed the $153 million acquisition of hemostat and sealant assets from Mallinckrodt Pharmaceuticals (NYSE:MNK). Baxter announced in January its plan to acquire the...
View ArticleClik here to view.
How CHF Solutions is using health economics to expand product adoption
Two years after CHF Solutions (NSDQ:CHFS) acquired Baxter‘s (NYSE:BAX) Aquadex fluid filtration device for $5 million, the company’s executives are working to weave together the evidence they need to...
View ArticleClik here to view.
Baxter beats The Street with Q1 results
Shares in Baxter (NYSE:BAX) rose today in pre-market activity after the medical device maker beat expectations on Wall Street with its first-quarter results. The Deerfield, Ill.-based company posted...
View ArticleClik here to view.
Baxter inks partnership deal with International Society of Nephrology
Baxter (NYSE:BAX) said today it inked a partnership deal with the International Society of Nephrology looking to advance awareness and therapy for patients with chronic kidney disease, primarily in...
View ArticleClik here to view.
Baxter wins FDA nod for Spectrum IQ infusion system
Baxter (NYSE:BAX) said today that it won FDA clearance for its Spectrum IQ infusion system with Dose IQ safety software. The company touted its system as the first of its kind to include bi-directional...
View ArticleClik here to view.
Baxter touts Theranova HDx dialysis tech study data
Baxter (NYSE:BAX) today released new data from studies exploring expanded hemodialysis with its Theranova dialyzer, touting the device’s ability to clear large middle molecules at a higher rate than...
View Article
